Geneva, Nov. 3 -- International Clinical Trials Registry received information related to the study (NCT07220694) titled 'Effects of Sabroxy(R) Supplementation on Insulin Resistance and Cognitive Function in Adults With Mild Cognitive Impairment and Insulin Resistance: A Randomized, Double-Blind, Placebo-Controlled Study' on Oct. 22.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor).
Primary Sponsor: SF Research Institute, Inc.
Condition:
Insulin Resistance
Mild Cognitive Impairment
Metabolic Dysfunction
Cognitive Decline
Neurodegenerative Disorders
Intervention:
Dietar...